CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-05 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise · Restricted Share Units | −21,387 | 64,164 | ||
| 2022-03-05 | Inbar Galia See "Remarks" | Option exercise | +5,710 | 15,366 | ||
| 2022-03-05 | Inbar Galia See "Remarks" | Option exercise · Restricted Share Units | −5,710 | 17,132 | ||
| 2022-03-05 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise | +23,764 | 135,027.51 | ||
| 2022-03-05 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise · Restricted Share Units | −23,764 | 71,293 | ||
| 2022-03-05 | Drape Eric Executive VP Global Operations | Option exercise | +22,576 | 89,406 | ||
| 2022-03-05 | Drape Eric Executive VP Global Operations | Option exercise · Restricted Share Units | −22,576 | 67,728 | ||
| 2022-03-05 | Dethlefs Sven EVP, North America Commercial | Option exercise | +24,952 | 172,374 | ||
| 2022-03-05 | Dethlefs Sven EVP, North America Commercial | Option exercise · Restricted Share Units | −24,952 | 74,857 | ||
| 2022-03-05 | Daniell Richard Exec. VP, European Commercial | Option exercise | +22,576 | 65,758 | ||
| 2022-03-05 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units | −22,576 | 67,728 | ||
| 2022-03-04 | Weiss Amir Chief Accounting Officer | Option exercise | +2,403 | 20,994.41 | ||
| 2022-03-04 | Weiss Amir Chief Accounting Officer | Option exercise · Restricted Share Units | −2,403 | 2,406 | ||
| 2022-03-04 | Weiss Amir Chief Accounting Officer | Grant or award · Restricted Share Units | +42,707 | 42,707 | ||
| 2022-03-04 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise | +37,939 | 59,319.39 | ||
| 2022-03-04 | Stark David Matthew Exec. VP Chief Legal Officer | Sale | −17,008 | $7.48 | $127K | 42,311.39 |
| 2022-03-04 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise | +13,930 | 56,241.39 | ||
| 2022-03-04 | Stark David Matthew Exec. VP Chief Legal Officer | Sale | −6,246 | $7.48 | $47K | 49,995.39 |
| 2022-03-04 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise · Restricted Share Units | −37,939 | 0 | ||
| 2022-03-04 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise · Restricted Share Units | −13,930 | 13,931 |
Page 37 of 76 · 1,517 trades